TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT02222649 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study NCT04148066 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01834950 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01479842 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT01803828 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT02718456 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03829371 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT04135872 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT04167150 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00238745 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02555397 — Safety Biomarker (SAF): Interleukin 12
Study NCT01565031 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT00801151 — Pharmacodynamic Biomarker (PDY): Histone acetylation
Study NCT02964572 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study NCT01658176 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT01658176 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04320472 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06584851 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT01796834 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01732406 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04178876 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT00874393 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00312546 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00312546 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT03275506 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04727996 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study NCT00157105 — Predictive Biomarker (PRD): Coagulation factor VIII
Genes: F8; F8C
Study NCT02026583 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Angiopoietin-2
Genes: ANGPT2
Study NCT03430362 — Predictive Biomarker (PRD): HBB mRNA
Genes: HBB
Study NCT01490047 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02195180 — Predictive Biomarker (PRD): ASNS mRNA
Genes: ASNS; TS11
Study NCT00253552 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00857909 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04650763 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04641234 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04641234 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01234025 — Predictive Biomarker (PRD): EIF4E mRNA
Genes: EIF4E; EIF4EL1; EIF4F
Study NCT01404702 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT04072952 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04072952 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04072952 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00958971 — Predictive Biomarker (PRD): FGFR1 mRNA
Genes: FGFR1; BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR
Study NCT00958971 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00958971 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT00958971 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02602002 — Pharmacodynamic Biomarker (PDY): Heat pain threshold
Study NCT04394585 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT01539902 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT03239847 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01366469 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study NCT01127464 — Predictive Biomarker (PRD): LY75 mRNA
Genes: LY75; CD205; CLEC13B
Study NCT01127464 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02381288 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT02622295 — Predictive Biomarker (PRD): PPARGC1B mRNA
Genes: PPARGC1B; PERC; PGC1; PGC1B; PPARGC1
Study NCT02622295 — Predictive Biomarker (PRD): PDK4 mRNA
Genes: PDK4; PDHK4
Study NCT02483858 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT01009970 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT01841021 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT02372513 — Predictive Biomarker (PRD): LIPA mRNA
Genes: LIPA
Study NCT00763295 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT02466035 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02466035 — Pharmacodynamic Biomarker (PDY): Histone acetylation
Study NCT02466035 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-21
Genes: MIR21
Study NCT03292744 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00738569 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01110525 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study NCT04432649 — Predictive Biomarker (PRD): CD276 mRNA
Genes: CD276; B7H3; PSEC0249; UNQ309/PRO352
Study NCT00405899 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT00134797 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT02272608 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02272608 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT03701022 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03034772 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03034772 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03933735 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT04626128 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04626128 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT03704363 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03676257 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03754088 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT03373188 — Predictive Biomarker (PRD): SEMA4D mRNA
Genes: SEMA4D; C9orf164; CD100; SEMAJ
Study NCT04464434 — Predictive Biomarker (PRD): CYCS mRNA
Genes: CYCS; CYC
Study NCT04191642 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study NCT03256305 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PSD mRNA
Genes: PSD; EFA6; EFA6A; KIAA2011; PSD1; TYL
Study NCT04508829 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01417923 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01417923 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03587272 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT04014686 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01248663 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT01996098 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01996098 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02632045 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02632045 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT02632045 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT02632045 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02451553 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02451553 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04812691 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03029689 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00523458 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03214471 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03214471 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01140152 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study NCT02512107 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01072734 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT01072734 — Pharmacodynamic Biomarker (PDY): Stromal cell-derived factor 1
Genes: CXCL12; SDF1; SDF1A; SDF1B
Study NCT03527758 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03406507 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT06719583 — Predictive Biomarker (PRD): GP2 mRNA
Genes: GP2
Study NCT03158571 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT03227458 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01698619 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02778542 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01814046 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00935597 — Predictive Biomarker (PRD): HDC mRNA
Genes: HDC
Study NCT01127074 — Predictive Biomarker (PRD): CD80 mRNA
Genes: CD80; CD28LG; CD28LG1; LAB7
Study NCT01127074 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT03906123 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT02835820 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03471650 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT03910842 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02353104 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01953263 — Predictive Biomarker (PRD): MFF mRNA
Genes: MFF; C2orf33; AD030; AD033; GL004
Study NCT02039492 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00048555 — Predictive Biomarker (PRD): CD80 mRNA
Genes: CD80; CD28LG; CD28LG1; LAB7
Study NCT02992106 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02757456 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT02757456 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02757456 — Surrogate Endpoint (SUR): Serum calcium
Study NCT02201992 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT03370419 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02334202 — Predictive Biomarker (PRD): POMC mRNA
Genes: POMC
Study NCT01092585 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT00543049 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT03386344 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00005456 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT01952002 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT01952002 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT01952002 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06247267 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03599440 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02475707 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study NCT02475707 — Predictive Biomarker (PRD): PRAME mRNA
Genes: PRAME; MAPE; OIP4
Study NCT03059147 — Predictive Biomarker (PRD): PI3 mRNA
Genes: PI3; WAP3; WFDC14
Study NCT01479244 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01479244 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02368288 — Monitoring Biomarker (MOI): HBV DNA
Study NCT03889951 — Predictive Biomarker (PRD): IKZF1 mRNA
Genes: IKZF1; IK1; IKAROS; LYF1; ZNFN1A1
Study NCT03889951 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT03656718 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT02845921 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00868972 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT00868972 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02761278 — Predictive Biomarker (PRD): HOXA10 mRNA
Genes: HOXA10; HOX1H
Study NCT02761278 — Predictive Biomarker (PRD): HOXA11 mRNA
Genes: HOXA11; HOX1I
Study NCT03103568 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT03103568 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT03103568 — Predictive Biomarker (PRD): CYP2E1 mRNA
Genes: CYP2E1; CYP2E
Study NCT02346903 — Predictive Biomarker (PRD): TRPV1 mRNA
Genes: TRPV1; VR1
Study NCT03869541 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02769390 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02391389 — Predictive Biomarker (PRD): DCC mRNA
Genes: DCC; IGDCC1
Study NCT04873544 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study NCT00676663 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT00349661 — Predictive Biomarker (PRD): VASP mRNA
Genes: VASP
Study NCT02338310 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03249272 — Predictive Biomarker (PRD): MVD mRNA
Genes: MVD; MPD
Study NCT02658929 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT03044834 — Predictive Biomarker (PRD): DICER1 mRNA
Genes: DICER1; DICER; HERNA; KIAA0928
Study NCT04298502 — Predictive Biomarker (PRD): KLRC2 mRNA
Genes: KLRC2; NKG2C
Study NCT00329186 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT03755271 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01786551 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03962088 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT04387201 — Predictive Biomarker (PRD): UCP1 mRNA
Genes: UCP1; SLC25A7; UCP
Study NCT04387201 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00239759 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT02396108 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02396108 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02396108 — Predictive Biomarker (PRD): ERBB4 mRNA
Genes: ERBB4; HER4
Study NCT02396108 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT01420224 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02031055 — Predictive Biomarker (PRD): TPI1 mRNA
Genes: TPI1; TPI
Study NCT00513123 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT03015363 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01212887 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01212887 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT01458288 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT01458288 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01458288 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT00293813 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00234663 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT00391053 — Surrogate Endpoint (SUR): Hemagglutination inhibition antibody
Study NCT03049579 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study NCT03049579 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT01528488 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01528488 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01092104 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT00929318 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00929318 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT00592943 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study NCT03935204 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02893943 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02447042 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04359654 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04359654 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT02420392 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT00657098 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00657098 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00479076 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04004221 — Predictive Biomarker (PRD): UBC mRNA
Genes: UBC
Study NCT04004221 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03013387 — Predictive Biomarker (PRD): SSTR2 mRNA
Genes: SSTR2
Study NCT00140179 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT01773707 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT02480023 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02715674 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT01482884 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Interleukin 13
Genes: IL13; NC30
Study NCT02587715 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT02654522 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT02463084 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT02463084 — Safety Biomarker (SAF): Clusterin
Genes: CLU; APOJ; CLI; KUB1; AAG4
Study NCT02463084 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03174652 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study NCT00751751 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02163499 — Surrogate Endpoint (SUR): Serum potassium
Study NCT00376935 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01084291 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03676400 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT00331799 — Predictive Biomarker (PRD): NE
Study NCT04348799 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT01461434 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01320683 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT04038723 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT01880008 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT03185858 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01862679 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01862679 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study NCT03236818 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT00759876 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT01033123 — Pharmacodynamic Biomarker (PDY): Gamma-Histone H2AX
Genes: H2AX; H2AFX
Study NCT01167972 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01167972 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01236144 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT01525888 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT01525888 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01363206 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01071499 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT01071499 — Predictive Biomarker (PRD): UGT2B7 mRNA
Genes: UGT2B7; UGTB2B9
Study NCT04078958 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT03594747 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03594747 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT01858441 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CYP17A1 mRNA
Genes: CYP17A1; CYP17; S17AH
Study NCT01858441 — Predictive Biomarker (PRD): TMPRSS2 mRNA
Genes: TMPRSS2; PRSS10
Study NCT01858441 — Predictive Biomarker (PRD): SLCO2B1 mRNA
Genes: SLCO2B1; KIAA0880; OATP2B1; OATPB; SLC21A9
Study NCT01858441 — Predictive Biomarker (PRD): SLCO1B3 mRNA
Genes: SLCO1B3; LST2; OATP1B3; OATP8; SLC21A8
Study NCT02676947 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT01301287 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT00075010 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT01235351 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT00480298 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study NCT03636932 — Predictive Biomarker (PRD): TF mRNA
Genes: TF; PRO1400
Study NCT01139619 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03846596 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT00728598 — Predictive Biomarker (PRD): CX3CL1 mRNA
Genes: CX3CL1; FKN; NTT; SCYD1; A-152E5.2